Dogwood Therapeutics, INC. (DWTX) — 10-Q Filings

10-Q Filings (6)

• Dogwood Therapeutics' Losses Soar Amid R&D Surge, Going Concern Doubt Looms — Nov 7, 2025 Risk: high
  Dogwood Therapeutics, Inc. (DWTX) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $30,476,921, a substantial
• Dogwood's Losses Soar Amid R&D Surge, Going Concern Doubts Emerge — Aug 13, 2025 Risk: high
  Dogwood Therapeutics, Inc. (DWTX) reported a significant increase in net loss for the six months ended June 30, 2025, reaching $14,732,305, a substantial rise f
• Dogwood Therapeutics Files Q1 2025 10-Q — May 9, 2025 Risk: medium
  Dogwood Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Virios Therapeutics, Inc., reported financial data for its
• Dogwood Therapeutics Files Q3 2024 10-Q — Nov 8, 2024 Risk: medium
  Dogwood Therapeutics, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Virios Therapeutics, Inc., is in the pharmace
• Virios Therapeutics Files Q2 2024 10-Q — Aug 9, 2024 Risk: medium
  Virios Therapeutics, Inc. filed its 10-Q for the period ending June 30, 2024. The company, incorporated in Delaware, is in the pharmaceutical preparations indus
• Virios Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk: low
  Virios Therapeutics, Inc. (DWTX) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Virios Therapeutics, Inc. filed a 10-Q report for the period endi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX